156 related articles for article (PubMed ID: 24687496)
1. Population pharmacokinetic/pharmacodynamic analysis of the bactericidal activities of sutezolid (PNU-100480) and its major metabolite against intracellular Mycobacterium tuberculosis in ex vivo whole-blood cultures of patients with pulmonary tuberculosis.
Zhu T; Friedrich SO; Diacon A; Wallis RS
Antimicrob Agents Chemother; 2014 Jun; 58(6):3306-11. PubMed ID: 24687496
[TBL] [Abstract][Full Text] [Related]
2. Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis.
Wallis RS; Dawson R; Friedrich SO; Venter A; Paige D; Zhu T; Silvia A; Gobey J; Ellery C; Zhang Y; Eisenach K; Miller P; Diacon AH
PLoS One; 2014; 9(4):e94462. PubMed ID: 24732289
[TBL] [Abstract][Full Text] [Related]
3. Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.
Wallis RS; Jakubiec W; Mitton-Fry M; Ladutko L; Campbell S; Paige D; Silvia A; Miller PF
PLoS One; 2012; 7(1):e30479. PubMed ID: 22279595
[TBL] [Abstract][Full Text] [Related]
4. Biomarker-assisted dose selection for safety and efficacy in early development of PNU-100480 for tuberculosis.
Wallis RS; Jakubiec W; Kumar V; Bedarida G; Silvia A; Paige D; Zhu T; Mitton-Fry M; Ladutko L; Campbell S; Miller PF
Antimicrob Agents Chemother; 2011 Feb; 55(2):567-74. PubMed ID: 21078950
[TBL] [Abstract][Full Text] [Related]
5. Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis.
Furin JJ; Du Bois J; van Brakel E; Chheng P; Venter A; Peloquin CA; Alsultan A; Thiel BA; Debanne SM; Boom WH; Diacon AH; Johnson JL
Antimicrob Agents Chemother; 2016 Nov; 60(11):6591-6599. PubMed ID: 27550361
[TBL] [Abstract][Full Text] [Related]
6. SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro.
Reddy VM; Dubuisson T; Einck L; Wallis RS; Jakubiec W; Ladukto L; Campbell S; Nacy CA
J Antimicrob Chemother; 2012 May; 67(5):1163-6. PubMed ID: 22258923
[TBL] [Abstract][Full Text] [Related]
7. Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model.
Williams KN; Stover CK; Zhu T; Tasneen R; Tyagi S; Grosset JH; Nuermberger E
Antimicrob Agents Chemother; 2009 Apr; 53(4):1314-9. PubMed ID: 19075058
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and whole-blood bactericidal activity against Mycobacterium tuberculosis of single doses of PNU-100480 in healthy volunteers.
Wallis RS; Jakubiec WM; Kumar V; Silvia AM; Paige D; Dimitrova D; Li X; Ladutko L; Campbell S; Friedland G; Mitton-Fry M; Miller PF
J Infect Dis; 2010 Sep; 202(5):745-51. PubMed ID: 20629533
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of TMC207 and its N-desmethyl metabolite in a murine model of tuberculosis.
Rouan MC; Lounis N; Gevers T; Dillen L; Gilissen R; Raoof A; Andries K
Antimicrob Agents Chemother; 2012 Mar; 56(3):1444-51. PubMed ID: 22155815
[TBL] [Abstract][Full Text] [Related]
10. Role of the Cys154Arg Substitution in Ribosomal Protein L3 in Oxazolidinone Resistance in Mycobacterium tuberculosis.
Makafe GG; Cao Y; Tan Y; Julius M; Liu Z; Wang C; Njire MM; Cai X; Liu T; Wang B; Pang W; Tan S; Zhang B; Yew WW; Lamichhane G; Guo J; Zhang T
Antimicrob Agents Chemother; 2016 May; 60(5):3202-6. PubMed ID: 26953211
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic evaluation of AZD5847 in a mouse model of tuberculosis.
Balasubramanian V; Solapure S; Shandil R; Gaonkar S; Mahesh KN; Reddy J; Deshpande A; Bharath S; Kumar N; Wright L; Melnick D; Butler SL
Antimicrob Agents Chemother; 2014 Jul; 58(7):4185-90. PubMed ID: 24820085
[TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis.
Alsultan A; Furin JJ; Du Bois J; van Brakel E; Chheng P; Venter A; Thiel B; Debanne SA; Boom WH; Diacon AH; Johnson JL; Peloquin CA
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739794
[TBL] [Abstract][Full Text] [Related]
13. Whole blood bactericidal activity during treatment of pulmonary tuberculosis.
Wallis RS; Vinhas SA; Johnson JL; Ribeiro FC; Palaci M; Peres RL; Sá RT; Dietze R; Chiunda A; Eisenach K; Ellner JJ
J Infect Dis; 2003 Jan; 187(2):270-8. PubMed ID: 12552451
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and Pharmacodynamic Modeling Analysis of Delpazolid (LCB01-0371) in Adult Patients with Pulmonary Tuberculosis.
Lee SM; Choi SC; Mun KR; Seo JY; Cho YL; Shim TS; Lim HS
J Clin Pharmacol; 2024 Jul; 64(7):849-859. PubMed ID: 38436463
[TBL] [Abstract][Full Text] [Related]
15. Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary Tuberculosis.
Kim JS; Kim YH; Lee SH; Kim YH; Kim JW; Kang JY; Kim SK; Kim SJ; Kang YS; Kim TH; Mok J; Byun MK; Park HJ; Joh JS; Park YB; Lim HS; Choi H; Lee SH; Kim H; Yang J; Kim H; Shen X; Alsultan A; Cho I; Geiter L; Shim TS
Antimicrob Agents Chemother; 2022 Feb; 66(2):e0168421. PubMed ID: 34871098
[TBL] [Abstract][Full Text] [Related]
16. Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.
Diacon AH; De Jager VR; Dawson R; Narunsky K; Vanker N; Burger DA; Everitt D; Pappas F; Nedelman J; Mendel CM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988102
[TBL] [Abstract][Full Text] [Related]
17.
McNeil MB; Dennison DD; Shelton CD; Parish T
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760892
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis.
Zhang M; Sala C; Dhar N; Vocat A; Sambandamurthy VK; Sharma S; Marriner G; Balasubramanian V; Cole ST
Antimicrob Agents Chemother; 2014 Jun; 58(6):3217-23. PubMed ID: 24663022
[TBL] [Abstract][Full Text] [Related]
19. Mycobactericidal activity of bedaquiline plus rifabutin or rifampin in ex vivo whole blood cultures of healthy volunteers: A randomized controlled trial.
Wallis RS; Good CE; O'Riordan MA; Blumer JL; Jacobs MR; Griffiss JM; Healan A; Salata RA
PLoS One; 2018; 13(5):e0196756. PubMed ID: 29718967
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of tedizolid, sutezolid, and sutezolid-M1 in non-human primates.
Kim S; Scanga CA; Miranda Silva C; Zimmerman M; Causgrove C; Stein B; Dartois V; Peloquin CA; Graham E; Louie A; Flynn JL; Schmidt S; Drusano GL
Eur J Pharm Sci; 2020 Aug; 151():105421. PubMed ID: 32531349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
